|
Volumn 13, Issue 4, 2013, Pages 447-454
|
Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMEDICAL TECHNOLOGY ASSESSMENT;
COMPARATIVE EFFECTIVENESS;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
INSURANCE;
LEGISLATION AND JURISPRUDENCE;
MANAGEMENT;
MASS COMMUNICATION;
ORGANIZATION AND MANAGEMENT;
PROGRAM EVALUATION;
COMPARATIVE EFFECTIVENESS RESEARCH;
DIFFUSION OF INNOVATION;
DRUG INDUSTRY;
ELIGIBILITY DETERMINATION;
HEALTH CARE COSTS;
HEALTH CARE REFORM;
HEALTH EXPENDITURES;
HEALTH POLICY;
HUMANS;
INSURANCE COVERAGE;
INSURANCE, HEALTH;
POLICY MAKING;
PROGRAM EVALUATION;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
|
EID: 84896554239
PISSN: None
EISSN: 17448379
Source Type: Journal
DOI: 10.1586/14737167.2013.815401 Document Type: Review |
Times cited : (6)
|
References (0)
|